⚛️ biophysics

Low CAR affinity enhances T-cell synapse dynamics and activation

This study demonstrates that low-affinity chimeric antigen receptors (CARs) enhance T-cell activation and clinical performance by promoting faster microcluster motion and more efficient signaling adaptor recruitment, thereby strengthening downstream signal propagation compared to high-affinity variants.

Original authors: Nguyen, C., Castro-Linares, G., Gatti, L. C. D. E., Sebestyen, Z., Fernandes, R. A., Tans, S. J., Farrell, M. V., Ganzinger, K. A.

Published 2026-10-12

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Nguyen, C., Castro-Linares, G., Gatti, L. C. D. E., Sebestyen, Z., Fernandes, R. A., Tans, S. J., Farrell, M. V., Ganzinger, K. A.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

In the battle against cancer, the immune system's T cells are elite soldiers, trained to recognize and destroy invaders. For decades, scientists have sought to arm these cells with synthetic receptors, known as chimeric antigen receptors, or CARs, to help them spot cancer cells more effectively. These engineered receptors act like specialized antennas, designed to lock onto specific proteins on the surface of tumor cells. Once the antenna locks on, it sends a signal to the T cell to attack. A long-held assumption in this field was that the stronger the lock—the higher the affinity between the receptor and the cancer protein—the better the soldier would perform. It seemed logical that a tighter grip would lead to a more powerful and lasting activation of the immune response. However, clinical observations have occasionally shown that receptors with a slightly looser grip can sometimes outperform their tighter counterparts, creating a puzzle for researchers trying to understand the mechanics of immune activation.

A team of researchers set out to solve this mystery by watching the very first moments when a T cell meets a cancer cell. Instead of using living tumor cells, which move and shift in three dimensions, making them hard to film in detail, they created a flat, glass-like surface coated with the specific cancer protein they wanted to study. This surface acted as a stand-in for a tumor cell, allowing them to use high-powered microscopes to watch the interaction from the side. They engineered T cells to carry two different types of receptors: one with a very strong, tight grip on the cancer protein, and another with a weaker, looser grip. They then placed these cells onto surfaces covered with varying amounts of the cancer protein, ranging from sparse to dense, to see how the cells reacted under different conditions.

What they discovered was that the strength of the grip fundamentally changed how the T cell organized itself. When the T cells with the weaker receptors encountered a dense field of cancer proteins, they formed dynamic, moving clusters that were highly efficient at gathering the internal machinery needed to launch an attack. These clusters moved quickly across the cell surface, gathering signaling proteins and fusing into a mature, organized structure that looked like a target with a bullseye. In contrast, the T cells with the strong, tight receptors often formed static, disorganized clusters that moved slowly and failed to organize properly. The tight grip seemed to trap the receptors in place, preventing them from moving and reorganizing effectively.

The researchers found that this difference in movement had a direct impact on the cell's internal signals. The fast-moving, loosely bound receptors were able to recruit signaling proteins more efficiently, triggering a stronger and more sustained release of calcium within the cell. This calcium surge is a critical switch that tells the T cell to fully activate and begin its work. Furthermore, the cells with the weaker receptors showed a higher rate of a specific protein moving into the cell's nucleus, a key step that turns on the genes necessary for the T cell to multiply and fight the cancer. The study suggests that the ability of the weaker receptor to let go and re-attach rapidly allows it to engage with multiple targets in a sequence, keeping the signal alive and the cell active.

This behavior was most pronounced when the cancer proteins were abundant on the surface, mimicking a tumor with high levels of the target protein. Under these conditions, the cells with the weaker receptors consistently outperformed those with the stronger ones, forming more mature synapses and generating stronger activation signals. The researchers propose that the looser grip allows for a kind of serial engagement, where a single receptor can touch many different targets in quick succession, whereas the tight grip locks the receptor onto a single target, limiting its ability to interact with others. This finding challenges the simple idea that "stronger is always better" in immune therapy. Instead, it suggests that the speed and fluidity of the interaction, driven by a carefully tuned, slightly weaker affinity, may be the key to unlocking a more powerful and effective immune response against cancer.

Technical Summary: Low CAR Affinity Enhances T-cell Synapse Dynamics and Activation

Problem Statement
Chimeric antigen receptors (CARs) are synthetic immunoreceptors used in cancer immunotherapy, typically comprising an antibody-derived scFv, a co-stimulatory domain, and a CD3ζ signaling module. While five of the seven FDA-approved CAR-T cell products targeting CD19 utilize the high-affinity FMC63 scFv, preclinical studies have demonstrated that CARs engineered with a lower-affinity CAT scFv domain often exhibit superior antigen-specific cytotoxicity, reduced toxicity, and improved antitumor activity. Despite these functional observations, the molecular mechanisms linking CAR affinity to early T-cell activation, synapse formation, and downstream signaling remain poorly understood. Specifically, it is unclear how different antigen-binding domains influence the spatiotemporal organization of CAR microclusters and the recruitment of signaling adaptors.

Methodology
To address these questions, the authors established a quantitative, high-resolution model system using supported lipid bilayers (SLBs) as surrogate tumor cell surfaces. This approach allowed for the use of total internal reflection fluorescence (TIRF) microscopy to visualize plasma membrane-proximal events without the complications of 3D cell movement or phototoxicity.

SLB Platform: The SLBs were functionalized with defined densities of CD19 (the CAR ligand) and ICAM-1 (to engage LFA-1). To enhance cell adhesion and contact footprint, a synthetic DNA-mediated adhesion system was employed, increasing the cell-SLB contact area by approximately 2.5-fold.
CAR Constructs: Jurkat E6.1 T cells were engineered to express either low-affinity (CAT, $K_D \approx 14.38$ nM) or high-affinity (FMC63, $K_D \approx 0.328$ nM) CD19-targeting CARs containing a 4-1BB co-stimulatory domain and CD3ζ.
Experimental Variables: The study systematically varied CD19 surface densities (sparse, intermediate, and dense) and CAR expression levels (low and high) on the T cells.
Imaging and Analysis: Cells were co-transduced with fluorescent reporters, including ZAP70-eGFP (to track signaling adaptor recruitment) and NFAT-eGFP (to monitor nuclear translocation). Calcium flux was measured using Fluo-4 AM.
Quantification: The authors utilized a convolutional neural network (CNN) trained on TIRF data to objectively classify immune synapses as "maturing" (forming a central supramolecular activation cluster, cSMAC) or "disorganized." Single-molecule tracking and trajectory analysis were used to quantify cluster velocity, directionality, and the stoichiometry of CD19 binding versus ZAP70 recruitment.

Key Contributions and Results

Synapse Maturation and Organization:
- The formation of mature immune synapses (characterized by the coalescence of peripheral microclusters into a central cSMAC) was jointly shaped by CD19 density and CAR expression levels.
- At low CAR expression levels on dense CD19 surfaces, low-affinity (CAT) CARs formed mature synapses more frequently (89%) compared to high-affinity (FMC63) CARs (77%).
- Maturing synapses exhibited significantly higher ZAP70 recruitment efficiency (ZAP70 per CD19 molecule) compared to disorganized synapses, regardless of CAR affinity.
Signaling Efficiency and Serial Triggering:
- In low-CAR-expressing cells interacting with intermediate and dense CD19 densities, low-affinity CAT CARs recruited similar or higher amounts of ZAP70 than high-affinity FMC63 CARs, despite binding fewer CD19 molecules.
- Consequently, the ZAP70 recruitment efficiency per engaged CD19 molecule was 1.2-fold (intermediate) to 1.9-fold (dense) higher for low-affinity CARs.
- The authors propose that the faster dissociation rate ( $k_{off}$ ) of low-affinity CARs facilitates "serial triggering," allowing a single CD19 molecule to sequentially engage multiple CARs, thereby amplifying receptor activation and sustaining ZAP70 recruitment within microclusters.
Microcluster Dynamics and Motility:
- Low-affinity CAT CAR microclusters exhibited significantly faster motion (up to 2-fold) compared to high-affinity FMC63 clusters, particularly in low-expression cells on dense CD19 surfaces.
- This increased velocity was observed both before and during ZAP70 colocalization. The authors suggest that the looser organization of low-affinity clusters, resulting from rapid unbinding, reduces steric hindrance and facilitates faster centripetal movement driven by retrograde F-actin flow.
- In contrast, high-affinity interactions appeared to constrain receptor turnover and cluster mobility, potentially limiting the accessibility of signaling adaptors.
Downstream Signaling (Calcium and NFAT):
- Low-affinity CAT CAR-T cells displayed more robust intracellular calcium ( $Ca^{2+}$ ) flux and a higher frequency of NFAT nuclear translocation compared to high-affinity FMC63 cells under low-expression, dense-CD19 conditions.
- Specifically, 65% of low-affinity cells showed robust $Ca^{2+}$ flux versus 40% for high-affinity cells. Similarly, 20% of low-affinity cells showed NFAT translocation versus 10% for high-affinity cells.
- These differences were less pronounced at high CAR expression levels, suggesting the advantage of lower affinity is most significant when antigen is abundant relative to receptor availability.

Significance
The paper provides a mechanistic basis for the clinically observed superior performance of affinity-tuned (lower-affinity) CD19 CAR-T cells. The authors conclude that weaker, lower-affinity CAR-antigen interactions paradoxically promote more productive T-cell activation than high-affinity binding. This is achieved through:

Enhanced receptor turnover and serial triggering.
More efficient recruitment of signaling adaptors (ZAP70) per engaged ligand.
Increased microcluster mobility and centripetal motion, which likely facilitates integration with membrane-associated signaling proteins (e.g., LAT) and sustained receptor phosphorylation.
Reduced steric constraints that might otherwise limit adaptor access in tightly bound, static high-affinity clusters.

The study highlights that optimal CAR design is not solely a function of maximizing binding affinity but requires a balance that promotes dynamic synapse organization and efficient signal propagation, particularly in environments with high antigen density.

More like this